817 Identification of Biomarkers and Mechanistic Insight for Upadacitinib in Crohn’s Disease: Serum Inflammatory Mediator Analysis From the Phase 2b CELEST StudyVermeire Séverine, Silvio Danese, Bram Verstockt et al.|The American Journal of Gastroenterology|2019Cited by 0